Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Freedom from Fear in 2009
December 15, 2008
- PDA Closure Set from Japan Lifeline Recommended for Approval
December 15, 2008
- 2 Drugs for CML, 2 Anti-HIV Drugs Recommended for Approval
December 8, 2008
- REGULATORY NEWS IN BRIEF
December 8, 2008
- NBI Opens Research Institute in Kobe
December 8, 2008
- JPMA to Support Researchers to Obtain iPS Cell-Related IP Rights
December 8, 2008
- Cell Transplantation Technology Developed for Serious Heart Failure
December 8, 2008
- R&D NEWS IN BRIEF -1-
December 8, 2008
- R&D NEWS IN BRIEF -2-
December 8, 2008
- TOPICS 2 articles
December 8, 2008
- 9 Organizations Jointly Call For Ban on Online Sales of Drugs
December 8, 2008
- VITAL KSK Holdings Aims at Sales of \600 Bil. in FY2012
December 8, 2008
- JACDS Objects to JODA's Voluntary GLs
December 8, 2008
- Price Negotiations Make Little Headway at Major Hospitals
December 8, 2008
- DPJ's Council Favors Restrictions of Online Sales of Drugs
December 8, 2008
- Yakult Honsha: Strong Sales of Elplat Prop Up Pharma Business
December 8, 2008
- Creams for Vaginal Candidiasis Recommended for Approval as Switch OTC Drugs
December 8, 2008
- TOP QUARK to Provide Int'l Clinical Development Project Management Services
December 8, 2008
- SELF-MEDICATION NEWS IN BRIEF
December 8, 2008
- Licensing Negotiations Underway for Drug for MS: MediciNova
December 8, 2008
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…